IP Verse

Merck Sharp & Dohme patent opposition analysis

The comprehensive analysis of Merck Sharp & Dohme opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Merck Sharp & Dohme

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP3322731	Method Of Treating Cancer Using Immune Checkpoint Inhibitor	BRISTOL MYERS SQUIBB	Oct 12, 2021	MERCK SHARP & DOHME
EP2382228	Compositions And Methods Of Treating Inflammatory And Autoimmune Diseases	AMGEN	May 26, 2021	MERCK SHARP & DOHME
EP2188371	Use Of Perfusion To Enhance Production Of Fed-Batch Cell Culture In Bioreactors	WYETH	Sep 20, 2018	MERCK SHARP & DOHME

Top companies who are the clients of Merck Sharp & Dohme

Company	Total
MERCK SHARP & DOHME	3